ES
34
3
RSG
71
3
LYB
39
2
CSCO
67
4
ROST
63
12
HD
57
2
NVDA
56
-4
LEG
36
4
SO
53
-4
CFG
70
6
USB
55
-6
BSX
67
-3
HPQ
63
6
LLY
37
-3
BWA
48
2
XYL
49
4
WAT
55
2
KMI
67
-2
TROW
56
5
FDX
43
3
ES
34
3
RSG
71
3
LYB
39
2
CSCO
67
4
ROST
63
12
HD
57
2
NVDA
56
-4
LEG
36
4
SO
53
-4
CFG
70
6
USB
55
-6
BSX
67
-3
HPQ
63
6
LLY
37
-3
BWA
48
2
XYL
49
4
WAT
55
2
KMI
67
-2
TROW
56
5
FDX
43
3
Financhill
Back

electroCore 10K Form

Buy
62

ECOR
electroCore

Last Price:
11.05
Seasonality Move:
2.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ECOR News And Ratings

See the #1 stock for the next 7 days that we like better than ECOR

ECOR Financial Statistics

Sales & Book Value

Annual Sales: $16.03M
Cash Flow: $-1.36M
Price / Cash Flow: 0
Annual Sales: $1.45
Price / Book: 7.77

Profitability

EPS (TTM): -1.77000
Net Income (TTM): $-12.69M
Gross Margin: $13.23M
Return on Equity: -144.52%
Return on Assets: -67.86%

electroCore Earnings Forecast

Key electroCore Financial Ratios

  • The Gross Profit Margin over the past 8 years for ECOR is 82.51%.
  • The Selling, General & Administrative Expenses for ECOR have been equal to 169.52% of Gross Profit Margin.
  • The Research & Development expenses have been 33.19% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of ECOR is -117.49% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

electroCore Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ECOR
CUSIP: 28531P
Website: electrocore.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.12
Quick Ratio: 1.71

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ECOR Technical Analysis vs Fundamental Analysis

Buy
62
electroCore (ECOR) is a Buy

Is electroCore a Buy or a Sell?

  • electroCore stock is rated a Buy
    The current electroCore [ECOR] share price is $11.21. The Score for ECOR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.